Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Role of Metformin in Reversing the Negative Impact of Hyperglycemia on Bone Healing Around Implants Inserted in Type 2 Diabetic Rats

Full text
Author(s):
Serrao, Caroline Ribeiro ; Bastos, Marta Ferreira ; Cruz, Daniele Ferreira ; Malta, Fernando de Souza ; Vallim, Paolla Camacho ; Duarte, Poliana Mendes
Total Authors: 6
Document type: Journal article
Source: INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS; v. 32, n. 3, p. 547-554, MAY-JUN 2017.
Web of Science Citations: 5
Abstract

Purpose: There is interest in establishing hypoglycemiant agents able to contain/revert the impact of diabetes mellitus on osseointegration. The purpose of this study was to assess the possible effect of metformin in reversing the negative effects of hyperglycemia on the healing of bone surrounding implants inserted in rats. Materials and Methods: Rats (10 per group) were assigned to one of the following groups: DM group: type 2 diabetic rats deprived of metformin (M) treatment; MDM group: type 2 diabetic rats under M treatment (40 mg/kg/day, starting on the 15th day after implant placement); control group: nondiabetic rats without M treatment. At 30 days after streptozotocin injection, titanium implants were placed in tibiae. Animals were euthanized 30 days after implant surgery. Bone-to-implant contact (BIC), bone area (BA), and the number of receptor activator of nuclear factor kappa B ligand (RANKL)- and osteoprotegerin (OPG)-stained cells were assessed in cortical and medullary areas. Results: The percentages of BIC and BA in the cortical bone were reduced in the DM and MDM groups compared with the control group (P < .05). The percentage of BA in the medullary region was reduced in the DM group compared with the control group (P < .05). The MDM group showed the greatest number of OPG-stained cells, while the DM group presented the greatest ratio of RANKL/OPG in the medullary area (P < .05). Conclusion: Metformin did not modulate the damaging effect of hyperglycemia on bone healing around implants at histometric levels, but increased the expression of OPG and decreased the RANKL/OPG ratio in the medullary area, yielding some molecular benefits in the osseointegration of implants under the hyperglycemic state. (AU)

FAPESP's process: 13/09628-2 - Impact of type 2 diabetes and metformin treatment on ligature-induced bone loss, alveolar bone healing and ex vivo cytokines production: study in rats
Grantee:Marta Ferreira Bastos
Support Opportunities: Regular Research Grants